Teladoc Health, Inc.

Equities

TDOC

US87918A1051

Healthcare Facilities & Services

Real-time Estimate Cboe BZX 12:56:16 2024-03-28 pm EDT 5-day change 1st Jan Change
15.3 USD +0.23% Intraday chart for Teladoc Health, Inc. +0.59% -28.68%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Teladoc Health Seeks M&A CI
Transcript : Teladoc Health, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 09:30 AM
Sector Update: Health Care Stocks Gain Late Afternoon MT
Sector Update: Health Care Stocks Stronger in Afternoon Trading MT
Teladoc Expands Obesity, Weight-Management Offering; Shares Rise MT
Teladoc Health Insider Sold Shares Worth $266,354, According to a Recent SEC Filing MT
Teladoc Health Insider Sold Shares Worth $433,854, According to a Recent SEC Filing MT
Transcript : Teladoc Health, Inc. Presents at TD Cowen 44th Annual Health Care Conference 2024, Mar-04-2024 02:50 PM
Leerink Partners Initiates Coverage on Teladoc With Market Perform Rating, $17 Price Target MT
Deutsche Bank Adjusts Teladoc Price Target to $22 From $23, Maintains Hold Rating MT
Health Care Down on a Mixed Growth View -- Health Care Roundup DJ
Sector Update: Health Care Stocks Mixed in Late Afternoon MT
Sector Update: Health Care Stocks Slipping Wednesday Afternoon MT
Citigroup Adjusts Teladoc Price Target to $19 From $21, Maintains Neutral Rating MT
Teladoc Shares Fall After Q4 Results, Guidance MT
Barclays Trims Price Target on Teladoc to $25 From $26, Maintains Overweight Rating MT
Canaccord Genuity Lowers Price Target on Teladoc to $28 From $34, Maintains Buy Rating MT
Piper Sandler Adjusts Price Target on Teladoc to $25 From $30, Maintains Overweight Rating MT
Traders Await Fed Minutes, Nvidia Earnings as US Equity Futures Drop Pre-Bell MT
RBC Cuts Price Target on Teladoc to $25 From $30, Notes 'Slower Expected Revenue Trajectory,' Keeps Outperform Rating MT
North American Morning Briefing : Stock Futures Fall With Nvidia Results, Fed Minutes Eyed DJ
Teladoc's Q4 Net Loss Narrows as Revenue Increases; Issues Q1, 2024 Guidance MT
Stocks to Watch : Palo Alto Networks, SolarEdge, Teladoc Health DJ
Transcript : Teladoc Health, Inc., Q4 2023 Earnings Call, Feb 20, 2024
Teladoc Guides For Q1 Loss of $0.55-$0.45 on Revenue of $630-$645 Million, vs CIQ Analyst Consensus of GAAP Loss of $0.43/Share, Non-GAAP Loss of $0.37, on Revenue of $673 Million MT
Chart Teladoc Health, Inc.
More charts
Teladoc Health, Inc. provides virtual healthcare services. The Company operates through two segments: Teladoc Health Integrated Care (Integrated Care) and BetterHelp. The Integrated Care segment includes a suite of global virtual medical services including general medical, expert medical services, specialty medical, chronic condition management, mental health, and enabling technologies and enterprise telehealth solutions for hospitals and health systems. Services in this segment are distributed primarily on a business-to-business (B2B) basis. The BetterHelp segment primarily consists of its direct-to-consumer (D2C) mental health platform. The online counseling and therapy services are provided via its network of over 40,000 licensed clinicians leveraging its platform for Web, mobile app, phone, and text-based interactions. Its Teladoc Health family of brands, including Teladoc and BetterHelp, deliver access to advice and resolution for an array of healthcare needs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
28
Last Close Price
15.27 USD
Average target price
20.36 USD
Spread / Average Target
+33.36%
Consensus